Cargando…
Phosphocreatine recovery time constant (PCr) at peak exercise as a potential endpoint for clinical trials in PAD
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032365/ http://dx.doi.org/10.1186/1532-429X-18-S1-P352 |
_version_ | 1782454983352909824 |
---|---|
author | Gonzalez, Jorge A Li, Yan Shaw, Peter W Balfour, Pelbreton Yang, Yang Kay, Jennifer DiMaria, Joseph Weltman, Arthur Salerno, Michael Meyer, Craig H Epstein, Frederick H Kramer, Christopher M |
author_facet | Gonzalez, Jorge A Li, Yan Shaw, Peter W Balfour, Pelbreton Yang, Yang Kay, Jennifer DiMaria, Joseph Weltman, Arthur Salerno, Michael Meyer, Craig H Epstein, Frederick H Kramer, Christopher M |
author_sort | Gonzalez, Jorge A |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5032365 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50323652016-09-29 Phosphocreatine recovery time constant (PCr) at peak exercise as a potential endpoint for clinical trials in PAD Gonzalez, Jorge A Li, Yan Shaw, Peter W Balfour, Pelbreton Yang, Yang Kay, Jennifer DiMaria, Joseph Weltman, Arthur Salerno, Michael Meyer, Craig H Epstein, Frederick H Kramer, Christopher M J Cardiovasc Magn Reson Poster Presentation BioMed Central 2016-01-27 /pmc/articles/PMC5032365/ http://dx.doi.org/10.1186/1532-429X-18-S1-P352 Text en © Gonzalez et al. 2016 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Gonzalez, Jorge A Li, Yan Shaw, Peter W Balfour, Pelbreton Yang, Yang Kay, Jennifer DiMaria, Joseph Weltman, Arthur Salerno, Michael Meyer, Craig H Epstein, Frederick H Kramer, Christopher M Phosphocreatine recovery time constant (PCr) at peak exercise as a potential endpoint for clinical trials in PAD |
title | Phosphocreatine recovery time constant (PCr) at peak exercise as a potential endpoint for clinical trials in PAD |
title_full | Phosphocreatine recovery time constant (PCr) at peak exercise as a potential endpoint for clinical trials in PAD |
title_fullStr | Phosphocreatine recovery time constant (PCr) at peak exercise as a potential endpoint for clinical trials in PAD |
title_full_unstemmed | Phosphocreatine recovery time constant (PCr) at peak exercise as a potential endpoint for clinical trials in PAD |
title_short | Phosphocreatine recovery time constant (PCr) at peak exercise as a potential endpoint for clinical trials in PAD |
title_sort | phosphocreatine recovery time constant (pcr) at peak exercise as a potential endpoint for clinical trials in pad |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032365/ http://dx.doi.org/10.1186/1532-429X-18-S1-P352 |
work_keys_str_mv | AT gonzalezjorgea phosphocreatinerecoverytimeconstantpcratpeakexerciseasapotentialendpointforclinicaltrialsinpad AT liyan phosphocreatinerecoverytimeconstantpcratpeakexerciseasapotentialendpointforclinicaltrialsinpad AT shawpeterw phosphocreatinerecoverytimeconstantpcratpeakexerciseasapotentialendpointforclinicaltrialsinpad AT balfourpelbreton phosphocreatinerecoverytimeconstantpcratpeakexerciseasapotentialendpointforclinicaltrialsinpad AT yangyang phosphocreatinerecoverytimeconstantpcratpeakexerciseasapotentialendpointforclinicaltrialsinpad AT kayjennifer phosphocreatinerecoverytimeconstantpcratpeakexerciseasapotentialendpointforclinicaltrialsinpad AT dimariajoseph phosphocreatinerecoverytimeconstantpcratpeakexerciseasapotentialendpointforclinicaltrialsinpad AT weltmanarthur phosphocreatinerecoverytimeconstantpcratpeakexerciseasapotentialendpointforclinicaltrialsinpad AT salernomichael phosphocreatinerecoverytimeconstantpcratpeakexerciseasapotentialendpointforclinicaltrialsinpad AT meyercraigh phosphocreatinerecoverytimeconstantpcratpeakexerciseasapotentialendpointforclinicaltrialsinpad AT epsteinfrederickh phosphocreatinerecoverytimeconstantpcratpeakexerciseasapotentialendpointforclinicaltrialsinpad AT kramerchristopherm phosphocreatinerecoverytimeconstantpcratpeakexerciseasapotentialendpointforclinicaltrialsinpad |